He commented: Our investment is based on the excellent improvement made by Activaero and its team since the first financing. The advancements within the existing study on severe asthma are exciting highly. We are convinced of the growth potential Activaero is normally unfolding with its proprietary clinical programs and the impact it’s managed pulmonary delivery technology will have on the treatment of various pulmonary diseases. Gerhard Scheuch, founder and CEO of Activaero stated: LSP was selected as a top tier life science investor that may support us and our strategy to provide innovative devices and therapies to individuals with severe lung illnesses.A digital practice completely, Washington Radiology Associates performs the interpretations and imaging at their six imaging centers in the greater Washington, DC, region. An AMICAS customer for 22 years, Washington Radiology Associates will add AMICAS PACS to its current imaging IT answer already in implementation, which includes AMICAS RIS, AMICAS Reach, AMICAS Dashboards, and AMICAS Financials, to streamline their functions and enable them to pursue home based business initiatives.82 million NIH grant to make stealth bombs for brain cancer treatment’Choosing to go ‘end-to-end’ with AMICAS is key for our practice.